Research indicates wearable ultrasound patch enhances REM sleep onset and duration — Evidence Review
Published in Nature Communications, by researchers from University of Texas at Austin, UT Health San Antonio, Virginia Tech
Researched by
— the AI search engine for science
Table of Contents
Researchers at the University of Texas at Austin have developed a wearable ultrasound patch (NEUSLeeP) that improved REM sleep onset and duration in a noninvasive manner, as published in Nature Communications. Related studies generally support the potential of ultrasound neuromodulation for sleep modulation and highlight the safety of non-pharmacological sleep interventions.
- The new findings expand on preclinical research showing that focused ultrasound can modulate sleep architecture—primarily in animal models—by demonstrating similar effects in human participants, including both healthy sleepers and those with sleep difficulties 1 6.
- Prior systematic reviews indicate that transcranial ultrasound stimulation is generally safe and can modulate brain activity, while non-pharmacological interventions, such as relaxation and physical sleep aids, have shown effectiveness in improving sleep quality in various populations 4 9 13.
- While some studies have explored related ultrasound-based interventions (e.g., stellate ganglion blocks) for postoperative sleep improvement, the NEUSLeeP patch represents a novel, noninvasive, at-home approach for REM sleep enhancement 5 7.
Study Overview and Key Findings
Sleep disturbances, particularly disruptions to REM sleep, have been linked to mood disorders, stress adaptation, and overall well-being. Existing treatments for sleep problems often involve medications or behavioral interventions, which can have side effects or may not directly target the neural circuits involved in REM sleep. The NEUSLeeP patch aims to fill this gap by providing a noninvasive, wearable solution that delivers gentle ultrasound stimulation to deep brain regions while simultaneously monitoring brain activity. This approach could offer a new avenue for at-home management of sleep disorders and for advancing research into the neural mechanisms underlying sleep.
The study's significance lies in its demonstration of targeted, noninvasive REM sleep enhancement in humans, and its potential implications for treating conditions such as depression, PTSD, and insomnia. The device's ease of use and safety profile also position it as a promising tool for both clinical and research applications.
| Property | Value |
|---|---|
| Organization | University of Texas at Austin, UT Health San Antonio, Virginia Tech |
| Journal Name | Nature Communications |
| Authors | Kai Wing Tang, Huiliang Wang, Gregory Fonzo, Vincent Mysliwiec, William D. Moscoso-Barrera, Mengxia Yu, Mengmeng Yao, Jinmo Jeong, Ilya Pyatnitskiy, Anakaren Romero Lozano, Jiachen Wang, Ju-Chun Hsieh, Tony Sungjin Chae, Daniel Song, Julieta Garcia, Rithvik Mittapalli, Adam Bush, Benjamin Baird, Wynn Legon |
| Population | Healthy sleepers and participants with sleep difficulties |
| Sample Size | 28 people |
| Methods | Non-randomized Controlled Trial (Non-RCT) |
| Outcome | REM sleep onset time, REM sleep duration, heart rate variability |
| Results | Participants entered REM sleep 43 minutes sooner and stayed 16 minutes longer. |
Literature Review: Related Studies
To contextualize these findings, we searched the Consensus database, which contains over 200 million research papers. The following search queries were used to identify relevant studies:
- wearable ultrasound patch REM sleep
- ultrasound sleep technology effects
- non-drug methods improving sleep quality
Below, we group findings from related studies into key thematic questions:
| Topic | Key Findings |
|---|---|
| How does focused ultrasound neuromodulation impact sleep architecture? | - Preclinical studies show that low-intensity transcranial ultrasound stimulation (TUS) can modulate REM and NREM sleep, increasing total sleep time and affecting sleep stage ratios in rodent models 1 6. - The effectiveness and direction of modulation appears to depend on the baseline sleep state and brain target 1 6. |
| What is known about the safety and efficacy of ultrasound-based neuromodulation in humans? | - Systematic reviews report that TUS is generally safe and noninvasive, with mild, transient adverse effects reported in a minority of human subjects 4. - Human studies have demonstrated that TUS can alter brain excitability and connectivity, and modulate behavior, but its clinical application for sleep remains early-stage 4. |
| How effective are non-pharmacological interventions for sleep improvement? | - Meta-analyses and reviews indicate that interventions such as physical sleep aids, relaxation techniques, and music can meaningfully improve inpatient sleep quality 9 13. - Light/noise reduction, melatonin, and cognitive-behavioral therapy for insomnia (CBT-I) are among the most promising non-drug approaches 9 11 13. |
| Are there clinical applications of ultrasound-guided procedures for sleep and recovery? | - Ultrasound-guided stellate ganglion block (SGB), while invasive, has been shown to reduce postoperative sleep disturbances and improve deep sleep quality 5 7. - These methods may alleviate stress responses and sleep disorders, particularly in postoperative or critically ill patients 5 7. |
How does focused ultrasound neuromodulation impact sleep architecture?
Both animal and early human studies indicate that focused ultrasound can modulate sleep stages, notably REM and NREM sleep. The NEUSLeeP patch builds upon this foundation by demonstrating REM sleep enhancement in human participants through a wearable, noninvasive device.
- Preclinical research in rodents and Alzheimer's disease models found that TUS can increase total sleep time and modify the balance between REM and NREM sleep, with effects depending on the initial sleep state and targeted brain region 1 6.
- The new study extends these results to humans, showing reduced REM latency and increased REM duration 3.
- Previous studies primarily used head-fixed or anesthesia-dependent setups, whereas the NEUSLeeP patch allows for natural, overnight, at-home use 3 6.
- The direction of sleep modulation (e.g., increased REM vs. decreased REM) may differ based on stimulation parameters and individual baseline sleep characteristics 1 6.
What is known about the safety and efficacy of ultrasound-based neuromodulation in humans?
Systematic reviews support the safety profile of TUS, with most adverse effects being mild and transient. While neuromodulatory effects on brain activity and behavior have been observed, clinical application for sleep disorders is still in early exploratory stages.
- Comprehensive reviews found that TUS is safe for human use, with no severe adverse effects reported across diverse populations 4.
- Mild side effects (e.g., headache, scalp heating, mood changes) occur in a small percentage of subjects 4.
- The NEUSLeeP study reported minimal adverse effects and high tolerability, aligning with prior safety data 3 4.
- The translation of neuromodulatory effects to clinical sleep improvement in humans is a new and growing area, with the NEUSLeeP study representing an important early clinical demonstration 3 4.
How effective are non-pharmacological interventions for sleep improvement?
A range of non-pharmacological interventions, including physical sleep aids, relaxation, and environmental modifications, are supported by evidence for improving sleep quality, particularly in hospital or long-term care settings.
- Meta-analyses show that physical sleep aids, relaxation, manual therapy, and music can lead to medium-to-large improvements in sleep quality among inpatients 13.
- Light/noise reduction and melatonin supplementation are also effective, though more research is needed to standardize interventions 9 11.
- Cognitive-behavioral therapy for insomnia (CBT-I) is considered promising, but implementation in non-research settings remains inconsistent 11.
- The NEUSLeeP patch adds to the array of non-drug interventions, offering a technological approach that targets deep brain circuits noninvasively 3 9 13.
Are there clinical applications of ultrasound-guided procedures for sleep and recovery?
Ultrasound-guided interventions such as stellate ganglion block (SGB) have demonstrated benefits for sleep quality and stress reduction in postoperative and critically ill patients, though these methods are invasive compared to wearable devices.
- SGB performed under ultrasound guidance has been shown to reduce insomnia, improve deep sleep stages, and decrease stress markers after surgery 5 7.
- These interventions are primarily used in acute clinical settings and require medical supervision 5 7.
- The NEUSLeeP patch differs by being noninvasive and suitable for home use, but both approaches leverage ultrasound technology to influence sleep and stress adaptation 3 5 7.
- Further research is needed to compare the efficacy and safety of noninvasive vs. invasive ultrasound-based interventions for different patient populations 3 5 7.
Future Research Questions
Despite promising early results, several unanswered questions remain regarding the long-term efficacy, optimal use, and broader applicability of wearable ultrasound neuromodulation for sleep. Further research is needed to address these gaps and determine how the NEUSLeeP patch and similar technologies can be integrated into clinical practice or used for other neuropsychiatric conditions.
| Research Question | Relevance |
|---|---|
| What are the long-term effects and safety of repeated overnight use of wearable ultrasound patches for sleep? | Understanding long-term safety and efficacy is critical before widespread adoption, as most current studies, including NEUSLeeP, assess short-term outcomes in small samples 3 4. Longitudinal data are needed to rule out subtle or cumulative adverse effects. |
| How does ultrasound neuromodulation compare to established non-pharmacological sleep interventions like CBT-I or melatonin? | Direct comparisons with existing interventions would help clarify the relative benefits, potential synergies, or limitations of wearable ultrasound devices versus standard non-drug treatments 9 11 13. |
| Can wearable ultrasound patches improve sleep and mental health outcomes in clinical populations such as PTSD or depression? | Given the association between REM sleep disruption and psychiatric disorders, evaluating the technology in these groups is essential to determine clinical utility and potential mood or stress regulation benefits 3 4. |
| What are the mechanisms underlying ultrasound-induced modulation of REM sleep in humans? | Elucidating the neural circuits and physiological changes involved will inform optimization of device parameters and identify potential off-target effects 1 3 6. |
| How can wearable ultrasound devices be integrated into personalized sleep medicine and at-home monitoring? | Exploring implementation in real-world, diverse populations will test scalability and inform guidelines for personalized sleep interventions, addressing an unmet need for accessible, noninvasive sleep technologies 3 9 13. |